Drug interactions between Kadcyla and Perjeta
|Kadcyla (ado-trastuzumab emtansine)|
Interactions between your drugs
There were no interactions found in our database between Kadcyla and Perjeta - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Kadcyla is in the drug class HER2 inhibitors.
- Kadcyla is used to treat the following conditions:
- Perjeta is a member of the drug class HER2 inhibitors.
- Perjeta is used to treat the following conditions:
Drug and food interactions
No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
The recommended maximum number of medicines in the 'HER2 inhibitors' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'HER2 inhibitors' category:
- ado-trastuzumab emtansine (active ingredient in Kadcyla (ado-trastuzumab emtansine))
- pertuzumab (active ingredient in Perjeta (pertuzumab))
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Drug Interaction Classification
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.